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Abstract
Background
Examination of factors independently associated with participation in mortality followback
surveys is rare, even though these surveys are frequently used to evaluate end-of-life care.
We aimed to identify factors associated with 1) participation versus non-participation and 2)
provision of an active refusal versus a silent refusal; and systematically examine reasons
for refusal in a population-based mortality followback survey.
Methods
Postal survey about the end-of-life care received by 1516 people who died from cancer
(aged18), identified through death registrations in London, England (response rate
39.3%). The informant of death (a relative in 95.3% of cases) was contacted 4–10 months
after the patient died. We used multivariate logistic regression to identify factors associated
with participation/active refusals and content analysis to examine refusal reasons provided
by 205 nonparticipants.
Findings
The odds of partaking were higher for patients aged 90+ (AOR 3.48, 95%CI: 1.52–8.00, ref:
20–49yrs) and female informants (AOR 1.70, 95%CI: 1.33–2.16). Odds were lower for hos-
pital deaths (AOR 0.62, 95%CI: 0.46–0.84, ref: home) and proxies other than spouses/part-
ners (AORs 0.28 to 0.57). Proxies of patients born overseas were less likely to provide an
active refusal (AOR 0.49; 95% CI: 0.32–0.77). Refusal reasons were often multidimen-
sional, most commonly study-related (36.0%), proxy-related and grief-related (25.1%
each). One limitation of this analysis is the large number of nonparticipants who did not pro-
vide reasons for refusal (715/920).
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Conclusions
Our survey better reached proxies of older patients while those dying in hospitals were
underrepresented. Proxy characteristics played a role, with higher participation from
women and spouses/partners. More information is needed about the care received by
underrepresented groups. Study design improvements may guide future questionnaire
development and help develop strategies to increase response rates.
Introduction
Mortality followback surveys with bereaved relatives are used in several countries such as US
[1], the UK [2], Japan [3] and Italy [4] to evaluate end-of-life care, but the method faces ethical
and methodological challenges [5]. From an ethical perspective, sensitive planning is required
to avoid distress to a population that can be vulnerable [6–8]. Researchers should make sure
they maximise research benefits, while minimising/not causing harm to participants [8–10].
From a methodological perspective, a core concern is how to increase participation to avoid
low response rates (RRs).
Low RRs can result in nonresponse bias when there are systematic differences between par-
ticipants and nonparticipants and these are correlated with the variables of interest in a study
[11–13]. Methods to increase the odds of response in surveys have been widely investigated
[12,14–19]. However, nonparticipation remains an unavoidable reality. Furthermore, compar-
ing participants to nonparticipants is the exception rather than the rule; information on non-
participants is rare in mortality followback surveys [13,20]. When this analysis is conducted,
the adopted statistical methods are usually not consistent [21–24] or not clear [1,25–27]. It is
therefore not surprising that factors such as ethnicity [21,28], age [21,27,29], relationship to
deceased [21], gender [29], place of death [22], interval from time to death [22] and social dep-
rivation [29] do not show a consistent association with participation across studies with
bereaved relatives, even when the studied population and survey methods used are similar.
Crucially, the use of multivariate analysis to adjust for potential confounders has been rarely
applied to examine nonresponse in this type of survey.
In addition to methodological issues, a key ethical concern in mortality followback surveys
is whether participants and nonparticipants are being harmed by research. Current evidence
suggests that most participants find it beneficial to take part and that many feel good about
having the opportunity to help others in similar situations [30–34]. Those who do not partici-
pate, however, might have different views. A few studies have investigated the reasons why
some bereaved relatives do not take part in mortality followback surveys. Their results suggest
that grief and strong emotions [22,35–39] are common refusal reasons. Others include being
“too busy” [36,37,39–42], not knowing the deceased [35,43], being too ill [36,39], or not being
interested [39–42]. A better understanding of why people refuse to take part is still needed, as
the knowledge can help identify areas in need of improvement in order to increase RRs.
This study aims to determine factors associated with participation in a cancer mortality fol-
lowback postal survey and to systematically investigate reasons for refusing to take part. It also
determines factors associated with providing an active refusal as opposed to a silent refusal (i.e.
those who did not contact the research team to refuse participation and did not return a com-
pleted questionnaire). With this knowledge, we are able to identify underrepresented groups
and ways to improve overall response in postal bereavement surveys.
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Materials and Methods
1 Study design and setting
The QUALYCARE study was a mortality followback postal survey aiming to examine varia-
tions in the quality and costs of end-of-life care, preferences and palliative outcomes associated
with death at home in cancer. The study took place in four health regions in London, United
Kingdom (UK) with contrasting cancer home death rates and deprivation levels. These were
chosen based on ecological analysis. The study protocol can be found elsewhere [44]. This anal-
ysis of the QUALYCARE dataset focuses on non-response, a key component of the study
which was pre-specified in the QUALYCARE protocol.
2 Participants and sampling
The study was conducted with proxies for people18 who lived in one of the four health
regions and died from cancer between 5th March 2009 and 4th March 2010 (one year period).
The deceased were identified from death registrations and the proxy was the person who regis-
tered the death (i.e. the informant of death). The Office for National Statistics (ONS) con-
ducted the sampling in two waves (Nov 2009 and May 2010). They selected all deaths
registered 4–10 months prior to when the survey would be sent by post and screened for fur-
ther eligibility criteria (deceased aged18, resident in one of the four included health regions,
cancer as the underlying cause of death). The sample was stratified by health region and place
of death. For each health region we included all deaths that took place at home, in hospices and
in nursing homes. We then drew a random sample of 150 hospital deaths per health region or
took all hospital deaths if the number was below 150. The latter happened in the two smallest
regions. A random sample of hospital deaths was drawn in the larger health regions to ensure
that hospital deaths did not drown out deaths taking place in other settings (the latter were all
included to ensure they were well represented within the sample size required). In 2009 and
2010 over 40% of cancer deaths (44.0% and 42.0% respectively) in England andWales occurred
in a public hospital [45,46]. Hospital cancer deaths are also more likely in urban areas such as
London [47]. Cases where the death took place in other places or when the place of death was
unknown, and deaths registered by coroners were excluded. Questionnaire packs were sent in
two waves (January and July 2010) to cover the one year period.
The sample size needed for the original objectives of the QUALYCARE study was calculated
based on Altman’s methods [48]; a total sample of ~500 participants was needed to enable
powered comparisons on preferences for place of death, help of community nursing and satis-
faction with GP care by place of death for the most detailed level of analysis (a case-control of
home vs. hospital deaths, which required ~350 participants). The RR was estimated at 38%
with an extra 10% of missing data. Further information is available elsewhere [44].
3 Recruitment
The ONS sent each of the eligible participants a questionnaire pack by post following an “opt-
out” recruitment approach. This was done on behalf of the research team as it did not have
access to patients or informants of death’s names and addresses. The pack included a personal-
ised invitation letter (with the potential participant’s name and address); an information leaflet
tailored to the specific health region explaining the purpose of the study and providing the
research team’s address and telephone number; a reply slip and a small freepost envelope
(addressed to the ONS) for people to refuse to take part if that was their wish; a leaflet produced
by the Royal College of Psychiatrists with information about bereavement and sources of
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support [49]; the study questionnaire (numbered, gender-specific and with a coloured cover)
and a large freepost envelope for returning the questionnaire to the research team.
Receiving a completed questionnaire was considered as consent to participate. Up to two
reminders were sent to people who did not respond at two and four weeks after the initial post-
ing; the second reminder included another copy of the questionnaire. Those who had sent their
refusals were coded as nonparticipants and did not receive any further reminders.
4 Data collection
Data were collected by using a purpose-built 44-page questionnaire (available from the
research team), a reply slip in the questionnaire pack and a standardised call recording form
which was completed for each telephone call answered by the research team (S1 and S2 Figs).
Further pseudo-anonymised socio-demographic data were provided by the ONS.
4.1 The questionnaire. QUALYCARE followed methods by Cartwright, McCarthy and
Addington-Hall for national surveys in England on experiences of care in the last year of life
[44]. The questionnaire included four other tools: the Client Service Receipt Inventory (CSRI),
the Palliative care Outcome Scale (POS), a health status measure (EuroQoL EQ-5D-3L) and
the Texas Revised Inventory of Grief (TRIG). Relevant socio-demographic information about
the patient and the proxy was collected in the questionnaire. The questionnaire was piloted
using cognitive interviewing with 20 bereaved relatives recruited via the palliative care depart-
ment of a hospital in London [34,50,51]. This helped to refine the methods and improve the
questionnaire.
4.2 Reply slip and calls. The reply slip had a box for potential participants to tick in case
they did not wish to take part. It also stated that, although not required, it would be helpful for
the researchers to know why they decided not to participate. The slip had space for open com-
ments and no reasons were suggested. The research team was also available over the telephone
during working hours to answer any queries.
4.3 Death registration information. The ONS provided the research team with a pseudo-
anonymised and encrypted dataset for the entire sample. This dataset had information on
patient’s region of residence, patient’s age, days and months from both actual death and regis-
tration of death until the date when the questionnaire was sent, place of death, patient’s gender,
patient’s country of birth, proxy’s relationship to the deceased, and underlying cause of death
(based on the 10th revision of the International Classification of Diseases—ICD-10). Underly-
ing cause of death referred to cancer deaths only (C00 to D48)) [52].
The ONS also provided overall Index of Multiple Deprivation (IMD) scores (2010) charac-
terising the patient’s area of residence (according to Lower layer Super Output Areas). The
overall IMD score is a single measure of multiple deprivation; it is a weighted area level aggre-
gation of specific dimensions of deprivation (income, employment, education, health, among
others) [53]. These were provided as overall scores and deciles, which were then recoded into
quintiles. The first quintile represents the most deprived areas and the fifth quintile represents
the least deprived areas.
5 Ethics
The study was approved by a NHS Research Ethics Committee (REC), namely the London—
Dulwich REC, formerly King’s College London REC (ref no.:09/H0808/85). The R&D offices
of the health regions included in the study were notified about the study. No approval was
needed as the participants were not recruited through National Health Services. Access to and
handling of the anonymised death registration data provided by the ONS was governed by a
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Data Access Agreement signed by the ONS and the Cicely Saunders Institute (where the
researchers were based).
Returning a completed questionnaire was considered as consent to participate. The Lon-
don-Dulwich REC approved this consent procedure. The research team had no access to par-
ticipant identifiable data (this was only accessed by the ONS) unless this was willingly provided
by participants at the end of the questionnaire (where they were asked if they wished to receive
a short summary of the study results and if they were happy to be contacted by the research
team).
The ‘opt out’ approach to recruitment was decided following debates with experts in ethics,
end of life care bereavement researchers and clinicians, consultation of national guidance, anal-
ysis of previous studies and of findings from the pilot study. Participants were informed in the
invitation letter that the study had an ‘opt-out’ approach, and there were detailed procedures
to ensure confidentiality and security of personal data. Participants were assured in the invita-
tion letter and also in the information leaflet that they were under no obligation to take part or
answer any questions that they considered distressing. Procedures were followed to identify
and handle distressed participants [44].
6 Statistical analysis
Descriptive statistics, univariate and multivariate analyses were performed with the software
PASW Statistics for Windows 18.0 (IBM).
We report descriptive data on the number of completed questionnaires, cumulative RRs,
distribution of RRs according to time of contact, reasons for refusing to take part in the study
and socio-demographic characteristics from participants and nonparticipants. Response rates
correspond to the number of returned questionnaires divided by the number of eligible people
to whom questionnaires were sent by post.
Participants and nonparticipants were compared on socio-demographic variables by using
descriptive statistics. We carried out univariate and multivariate logistic regression to identify
factors associated with participation and factors associated with active refusal. Variables were
chosen a priory based on factors which were previously associated with non-participation in
the literature [21,22,27–29].
Our analyses included the variables health region and place of death to control for any
design effect associated with the fact that our sample was stratified by these two variables. We
calculated unadjusted and adjusted odds ratios (OR and AOR respectively) with 95% confi-
dence intervals (CIs). We also evaluated how the multivariate models fit the observed data
(ROC curve, Nagelkerke R2, Hosmer-Lemeshow goodness-of-fit test). All potential explanatory
variables that we measured were included in the models and entered simultaneously. Tests
were two-tailed and p<0.05 was deemed significant in the final regression models. Cases with
missing data were excluded.
All reasons for refusal were independently read by two researchers (both psychologists) and
analysed line by line using content analysis. An inductive coding frame with categories and
subcategories was derived from the data. After agreement was reached for all categories and
subcategories, the same researchers independently coded each refusal. Kappa statistics were
used for each subcategory to verify the raters’ level of agreement. Strength of agreement was
assessed following Landis and Koch guidelines (almost perfect agreement 0.81–1.00; substan-
tial 0.61–0.80; moderate 0.41–0.60; poor<0.00) [54]. All discrepancies were discussed and a
final agreement was obtained by consensus in these cases.
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Results
1 Response rates
We sent 1516 questionnaire packs and received 596 completed questionnaires, resulting in a
39.3% RR (Fig 1). We received 71.6% (n = 427) of the completed questionnaires during the
first four weeks after these were sent by post (Fig 2). All but six questionnaires were returned 4
to 8 months (n = 324; 54.4%), 9 to 10 months (n = 169; 28.4%) or 11 to 12 months (n = 97;
16.3%) after the patient died. The median number of days from death to the return of a com-
pleted questionnaire was 232.50 days (interquartile range: 191.25–281.00). Response rates var-
ied from 32.4% in heath region 2 to 46.6% in health region 1, and were highest in Wave 1
(41.2%) compared to Wave 2 (37.2%).
2 Sample characteristics
60.5% of participants were women and the majority were either the patient’s sons or daughters
(46.2%) or their spouse/partner (37.6%). There was a similar proportion of male (51.5%) and
female (48.5%) patients represented in the survey. Patient’s median age at death was 77.0
[interquartile range 66.0–84.0]. The most common types of cancer were digestive (27.9%) and
respiratory or intra-thoracic (21.5%) (Table 1).
3 Factors associated with participation
When comparing participants with nonparticipants using univariate statistics, there was an
under-representation of people living in more deprived areas except for the 4th quintile (OR
ranged from 0.44 for the 1st quintile to 0.63 for the 2nd quintile) and deaths outside home (OR
ranged from 0.58 for hospital to 0.70 for hospice) and cases in which the person who registered
the death (proxy) was the patient’s son or daughter, brother or sister, niece/nephew or other
(OR ranged from 0.35 for other to 0.58 for a son/daughter). On the other hand, we observed an
over-representation of patients aged 90+ (OR 2.37; 95% CI:1.25–4.51) and proxies who were
women (OR 1.72; 95% CI:1.38–2.14). There were no significant differences between partici-
pants and nonparticipants in patient’s country of birth, patient’s gender, type of cancer and
days from death to contact by researchers (Table 2).
Multivariate analysis using logistic regression showed that patient’s age, place of death,
proxy’s gender and relationship to patient were independently associated with participation
(Table 2). The odds of taking part were highest if the patient was aged 90+ (AOR 3.48; 95%
CI:1.52–8.00) and the proxy was a woman (AOR1.70; 95%CI:1.33–2.16). The odds of being a
participant were lowest if the patient died in hospital (AOR 0.62; 95%CI:0.46–0.84) and the
proxy was not a spouse/partner (except for brother/sister and parents; AOR ranged from 0.28
for other to 0.57 for a son/daughter).
4 Active refusal and associated factors
From the 920 nonparticipants, 348 (37.8%) actively refused to take part (either by calling the
team, sending back the entire pack, posting a letter or the reply slip). The remaining nonpartic-
ipants (n = 572) did not contact the research team to refuse participation and did not return a
completed questionnaire (i.e. the silent refusals) (Table 3). These corresponded to 539 (94.2%)
non-participants who did not contact the research team in any way, 25 (4.4%) who called the
research team stating they would try to complete the questionnaire but never managed to do
so, three (0.5%) who informed the research team that they had passed the questionnaire on to
someone else but the research team never received them and five (0.9%) questionnaire packs
which were returned unopened because addressee had moved away (Fig 1). Eight potential
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participants who had sent a reply slip refusing participation changed their minds and later sent
a completed questionnaire by post (these were included only in the participants’ group).
Similarly to the comparison between participants and nonparticipants, when comparing
those who provided active refusals with the silent refusals using univariate analysis, proxies of
patients who lived in the two most deprived areas (OR 0.55 for the 1st quintile and 0.57 for the
2nd quintile) or who lived in health region 2 (OR 0.62; 95% CI:0.42–0.91) or health region 4
Fig 1. QUALYCARE flow diagram.NHS, National Health Services.
doi:10.1371/journal.pone.0146134.g001
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(OR 0.62; 95% CI:0.41–0.93), proxies who were the patient’s son/daughter (OR 0.31; 95%
CI:0.22–0.44) or other (OR 0.40; 95% CI:0.20–0.78) provided active refusals less often. Infor-
mants of patients aged 90+ (OR 2.77; 95% CI:1.16–6.59) and 80–89 (OR 2.10; 95% CI:1.07–
4.13) more often actively refused to take part compared to informants of patients aged 20–49;
female proxies were also more likely to provide active refusals (OR 1.84; 95% CI:1.38–2.45).
Proxies of patients who were born overseas provided active refusals less often than proxies of
patients who were born in the country (OR 0.51; 95% CI:0.35–0.72) (Table 4).
Multivariate analysis using logistic regression showed that the patient’s age, proxies’ gender,
relationship to patient and patient’s country of birth were independently associated with
actively refusing to take part in the survey (Table 4). Informants of patients aged 70+ (AOR
ranged from 3.42 for the 70–79 age group to 6.59 for the 90+ age group) and female proxies
(AOR 1.58; 95%CI:1.14–2.20) were significantly more likely to give an active refusal. The odds
were lower if the informant was a son/daughter (AOR 0.26; 95% CI:0.18–0.40), a grandchild
(AOR 0.19; 95% CI:0.05–0.70) or other (AOR 0.25; 95% CI:0.11–0.56) or if patient was born
overseas (AOR 0.49; 95%CI:0.32–0.77). Area social deprivation and health region lost statistical
significance after adjusting for other factors. Timing since death, patient’s gender, place of
death, and type of cancer were not associated with the provision of active refusals.
5 Reasons for refusal
From the 348 nonparticipants who actively refused to take part, 205 (58.9%) justified their
decision. Of these, 80.0% wrote their reasons in the reply slip (n = 164), 17.6% (n = 36) gave
reasons over the phone and 2.4% (n = 5) wrote a letter to the research team. In total, 350 refusal
reasons were given, with 38.1% (n = 78) giving more than one reason (range 1 to 7 reasons).
Fig 2. Cumulative response rates by wave (1, 2 and both) and type of participant (early, middle and late).
doi:10.1371/journal.pone.0146134.g002
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Table 1. Characteristics of participants and nonparticipants.
Characteristics* All sampled deaths (n = 1516) A) Participants (n = 596) B) Nonparticipants (n = 920)
Patient gender
Male 775 (51.1%) 307 (51.5%) 468 (50.9%)
Female 741 (48.9%) 289 (48.5%) 452 (49.1%)
Patient age
Median age (IQR) 76.0 (66.0–83.0) 77.0 (66.0–84.0) 75.5 (66.0–82.0)
20–49 72 (4.7%) 23 (3.9%) 49 (5.3%)
50–59 142 (9.4%) 50 (8.4%) 92 (10.0%)
60–69 264 (17.4%) 118 (19.8%) 146 (15.9%)
70–79 455 (30.0%) 151 (25.3%) 304 (33.0%)
80–89 490 (32.3%) 205 (34.4%) 285 (31.0%)
90+ 93 (6.1%) 49 (8.2%) 44 (4.8%)
Patient’s country of birth
Born in the UK or Ireland 1223 (81.0%) 497 (83.4%) 726 (79.4%)
Born overseas† 287 (19.0%) 99 (16.6%) 188 (20.6%)
IMD score for lower super output area where patient lived
Median IMD score (IQR) 17.3 (9.5–30.4) 14.4 (7.8–27.0) 19.1 (10.1–32.2)
5th Quintile (least deprived) 329 (21.7%) 161 (27.0%) 168 (18.3%)
4th Quintile 275 (18.1%) 120 (20.1%) 155 (16.8%)
3rd Quintile 260 (17.2%) 94 (15.8%) 166 (18.0%)
2nd Quintile 363 (23.9%) 136 (22.8%) 227 (24.7%)
1st Quintile (most deprived) 289 (19.1%) 85 (14.3%) 204 (22.2%)
Health region where patient lived
Health region 1 487 (32.1%) 227 (38.1%) 260 (28.3%)
Health region 2 293 (19.3%) 95 (15.9%) 198 (21.5%)
Health region 3 481 (31.7%) 184 (30.9%) 297 (32.3%)
Health region 4 255 (16.8%) 90 (15.1%) 165 (17.9%)
Type of cancer (underlying cause of death)
Digestive organs 422 (27.8%) 166 (27.9%) 256 (27.8%)
Respiratory and intra-thoracic organs 327 (21.6%) 128 (21.5%) 199 (21.6%)
Eye, brain and other parts of CNS 46 (3.0%) 27 (4.5%) 19 (2.1%)
Breast 129 (8.5%) 51 (8.6%) 78 (8.5%)
Lymphoid/haematopoietic/related tissue 111 (7.3%) 38 (6.4%) 73 (7.9%)
Male genital organs 117 (7.7%) 42 (7.0%) 75 (8.2%)
Female genital organs 65 (4.3%) 26 (4.4%) 39 (4.2%)
Urinary tract 84 (5.5%) 39 (6.5%) 45 (4.9%)
Lip, oral cavity and pharynx 23 (1.5%) 6 (1.0%) 17 (1.8%)
Melanoma and skin 26 (1.7%) 12 (2.0%) 14 (1.5%)
Uncertain/unspeciﬁed/other 166 (11.1%) 61 (10.2%) 105 (11.5%)
Place of death
Home 368 (24.3%) 175 (29.4%) 193 (21.0%)
Hospital 513 (33.8%) 177 (29.7%) 336 (36.5%)
Hospice 512 (33.8%) 199 (33.4%) 313 (34.0%)
Nursing home 123 (8.1%) 45 (7.6%) 78 (8.5%)
Gender of proxy
Male 649 (47.4%) 220 (39.5%) 429 (52.8%)
Female 720 (52.6%) 337 (60.5%) 383 (47.2%)
Proxy’s relationship to patient
(Continued)
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Sixty-four percent of the nonparticipants who provided reasons for refusal were women;
75.6% were proxies of patients aged 70–90+ years old, 40.5% were informants for patients who
had died in a hospital and 33.7% for patients who had died in a nursing home.
Through content analysis, we identified seven categories of reasons for refusal (study-
related, proxy-related, grief-related, life-related, care-related, non-specific and other) and 34
subcategories (Table 5). Coding agreement between raters was almost perfect (.81) for 23
sub-categories, substantial (0.61 &0.80) for eight sub-categories, moderate (0.41 &
0.60) for two and poor (<0.00) for one sub-category (‘feels nothing more to be said about the
care received’).
The most common reasons were study-related (36.0% or 126 reasons). These referred to the
informants feeling that the questions were not applicable to the patient’s case, the question-
naire was too long, questions were upsetting, or beliefs that the questionnaire would not make
any difference. Proxy and grief related-reasons were the second most frequently mentioned
reasons (each accounting for 25.1% of all reasons or 88 reasons each). Proxy-related reasons
were provided by professionals who registered the death of a patient when there was no family
around, relatives who felt they had no knowledge about the care received, those replying on
behalf of their relatives who were the main carers, or the main carers themselves stating they
were disabled/fragile and could not therefore complete the questionnaire. The most common
grief-related reasons were from nonparticipants stating that they were still grieving and it
would be too upsetting or painful to take part. Other reasons for refusal were life-related (4.6%
of all reasons), such as being too busy to take part; care-related (2.3%) such as stating that
patient received good care, and non-specific (4.9%). The latter referred to nonparticipants sim-
ply stating that they did not wish to take part. Less than 3.0% of reasons were coded as “other”
and these are fully described in Table 5. Examples of nonparticipant quotes by main categories
are shown in Table 6.
Discussion
Using multivariate analysis of socio-demographic population-based data, the QUALYCARE
study identified important factors associated with participation in a postal mortality followback
Table 1. (Continued)
Characteristics* All sampled deaths (n = 1516) A) Participants (n = 596) B) Nonparticipants (n = 920)
Spouse or partner 413 (29.9%) 211 (37.6%) 202 (24.7%)
Son/daughter 688 (49.9%) 259 (46.2%) 429 (52.4%)
Brother/sister 108 (7.8%) 37 (6.6%) 71 (8.7%)
Mother/father 17 (1.2%) 8 (1.4%) 9 (1.1%)
Niece/nephew 70 (5.1%) 23 (4.1%) 47 (5.7%)
Grandson/granddaughter 20 (1.4%) 6 (1.1%) 14 (1.7%)
Other 64 (4.6%) 17 (3.0%) 47 (5.7%)
Days death registration to contact
Median days (IQR) 213.00 (167.25–258.00) 210.00 (168.00–256.00) 215.00 (166.00–258.00)
Days death to contact
Median days (IQR) 213.00 (167.00–259.00) 209.00 (168.00–256.75) 215.00 (167.00–261.00)
Abbreviations: IQR, Interquartile range; IMD, Index of Multiple Deprivation; CNS, Central Nervous System.
*There were no missing data on patient’s gender, age, place of death, cancer type, region and IMD score. Missing data was 0.4% (country of birth), 9.0%
(proxy’s relationship to patient), 9.7% (proxy’s gender) and 0.1% (days death to contact)
† There were 76 overseas countries of birth, none with more than 19 counts.
doi:10.1371/journal.pone.0146134.t001
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Table 2. Factors associated with participation.
Factors Response rate Univariate analysis p-values Multivariate analysis* p-values
n OR (95% CI) n AOR (95% CI)
Gender of patient
Male 39.6% 775 Ref. p = 0.807 697 Ref. p = 0.628
Female 39.0% 741 0.98 (0.79–1.20) 672 1.07 (0.82–1.40)
Age of patient
20–49 31.9% 72 Ref. p = 0.001 64 Ref. p<0.001
50–59 35.2% 142 1.16 (0.63–2.12) 126 1.18 (0.56–2.49)
60–69 44.7% 264 1.72 (0.99–2.99) 239 1.80 (0.88–3.65)
70–79 33.2% 455 1.06 (0.62–1.80) 403 1.15 (0.57–2.32)
80–89 41.8% 490 1.53 (0.91–2.60) 454 1.88 (0.93–3.81)
90+ 52.7% 93 2.37 (1.25–4.51) 83 3.48 (1.52–8.00)
Patient’s country of birth
Born in the UK or Ireland 40.6% 1223 Ref. p = 0.056 1111 Ref. p = 0.554
Born overseas 34.5% 287 0.77 (0.59–1.01) 258 0.91 (0.67–1.24)
IMD 2010 score
5th Quintile (least deprived) 48.9% 329 Ref. p<0.001 311 Ref. p = 0.050
4th Quintile 43.6% 275 0.81 (0.59–1.11) 259 0.79 (0.56–1.13)
3rd Quintile 36.2% 260 0.59 (0.42–0.82) 225 0.66 (0.45–0.97)
2nd Quintile 37.5% 363 0.63 (0.46–0.85) 329 0.73 (0.51–1.05)
1st Quintile (most deprived) 29.4% 289 0.44 (0.31–0.61) 245 0.50 (0.31–0.80)
Health region where patient lived
Health region 1 46.6% 487 Ref. p<0.001 467 Ref. p = 0.120
Health region 2 32.4% 293 0.55 (0.41–0.74) 249 0.84 (0.55–1.28)
Health region 3 38.3% 481 0.71 (0.55–0.92) 444 0.76 (0.57–1.01)
Health region 4 35.3% 255 0.63 (0.46–0.85) 209 1.09 (0.74–1.61)
Type of cancer (underlying cause of death)
Digestive organs 39.3% 422 Ref. p = 0.222 379 Ref. p = 0.421
Respiratory and intra-thoracic organs 39.1% 327 0.99 (0.74–1.33) 293 1.02 (0.73–1.42)
Eye, brain and other parts of CNS 58.7% 46 2.19 (1.18–4.07) 43 1.97 (1.00–3.88)
Breast 39.5% 129 1.01 (0.67–1.51) 120 0.98 (0.61–1.56)
Lymphoid/haematopoietic/related tissue 34.2% 111 0.80 (0.52–1.24) 100 0.92 (0.56–1.49)
Male genital organs 35.9% 117 0.86 (0.56–1.32) 105 0.75 (0.46–1.22)
Female genital organs 40.0% 65 1.03 (0.60–1.75) 59 1.14 (0.62–2.08)
Urinary tract 46.4% 84 1.34 (0.83–2.14) 76 1.35 (0.80–2.28)
Lip, oral cavity and pharynx 26.1% 23 0.54 (0.21–1.41) 21 0.54 (0.20–1.50)
Melanoma and skin 46.2% 26 1.32 (0.60–2.93) 25 1.35 (0.57–3.19)
Uncertain/unspeciﬁed/other 36.7% 166 0.90 (0.62–1.30) 148 0.89 (0.59–1.35)
Place of death
Home 47.6% 368 Ref. p = 0.001 355 Ref. p = 0.020
Hospital 34.5% 513 0.58 (0.44–0.76) 456 0.62 (0.46–0.84)
Hospice 38.9% 512 0.70 (0.54–0.92) 455 0.74 (0.55–1.00)
Nursing home 36.6% 123 0.64 (0.42–0.97) 103 0.68 (0.42–1.10)
Gender of proxy
Male 33.9% 649 Ref. p<0.001 649 Ref. p<0.001
Female 46.8% 720 1.72 (1.38–2.14) 720 1.70 (1.33–2.16)
Proxy’s relationship to patient
Spouse or partner 51.1% 413 Ref. p<0.001 413 Ref. p<0.001
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survey. We found that deaths in hospital and younger adult patients were underrepresented.
We also found that similar factors were associated with both participation and giving an active
refusal, except for country of birth which was only significant for the latter. Women and prox-
ies of older patients were more likely to participate in the survey and also more likely to actively
refuse when they decided not to take part. Likewise, relatives other than the spouse/partner
were less likely to participate and also less likely to actively refuse when the decided not to par-
ticipate. Through content analysis, we identified reasons for refusal and found that these were
often multidimensional. Although grieving was an important reason, other issues related to
the study itself and its design were also prominent. This suggests scope for improvement and
potential increase in RRs.
The study’s RR is low compared to bereavement studies carried out in Italy (65%RR) [22],
the United States (65% cooperation rate) [1] and the two recent national bereavement surveys
carried out in England (46% RR for each) [2,55], but it is in line with many others [23–
26,35,37,56,57] and 1% higher than we had estimated. Although we followed evidence-based
strategies to increase RRs (e.g. follow-up contact, provision of second copy of questionnaire
and use of a personalised questionnaire) [17], the topic was sensitive and we used a long ques-
tionnaire to meet our research aims. In addition, QUALYCARE was conducted in London, the
UK city with the highest proportion of ethnic minorities [58]. All these factors were previously
found to affect RRs [1,12,20]. Nonetheless, in the case of this analysis, non-response posed no
challenges; on the contrary, it made the regression analyses easier because there was a reason-
able number of “events” (i.e. non-participation) to do the modelling.
QUALYCARE was especially funded and designed to investigate the care provided to
patients with cancer. This is a common cause of death (29% in 2013) in England and Wales
[59] and was responsible for 25% of all deaths in Europe in 2010 [60], but as a consequence
Table 2. (Continued)
Factors Response rate Univariate analysis p-values Multivariate analysis* p-values
n OR (95% CI) n AOR (95% CI)
Son or daughter 37.6% 688 0.58 (0.45–0.74) 688 0.57 (0.43–0.75)
Brother or sister 34.3% 108 0.50 (0.32–0.78) 108 0.63 (0.39–1.01)
Parent 47.1% 17 0.85 (0.32–2.25) 17 1.14 (0.35–3.75)
Niece/nephew 32.9% 70 0.47 (0.27–0.80) 70 0.38 (0.21–0.68)
Grandchild 30.0% 20 0.41 (0.16–1.09) 20 0.29 (0.10–0.84)
Other 26.6% 64 0.35 (0.19–0.62) 53 0.28 (0.14–0.56)
Days from death to contact
110–150 40.4% 240 Ref. p = 0.251 215 Ref. p = 0.755
151–180 36.3% 256 0.84 (0.59–1.21) 227 0.89 (0.60–1.34)
181–210 45.6% 250 1.24 (0.86–1.77) 232 1.24 (0.83–1.85)
211–240 38.3% 248 0.92 (0.64–1.32) 224 0.97 (0.65–1.46)
241–270 39.2% 217 0.95 (0.65–1.38) 206 0.98 (0.65–1.49)
271–300 34.5% 220 0.78 (0.53–1.14) 190 0.95 (0.62–1.46)
301–330 42.9% 84 1.11 (0.67–1.83) 75 1.16 (0.65–2.05)
Abbreviations: UK, United Kingdom; IMD, Index of Multiple Deprivation; CNS, Central Nervous System; OR, odds ratio; AOR, adjusted odds ratio; CI,
conﬁdence intervals
*All characteristics of the patients and the informants of death, including timing of contact were entered simultaneously in the regression model (N = 1369,
excluding 147 cases with missing data, i.e. 9.7% of all 1516 cases).Model-ﬁtting statistics: Hosmer and Lemeshow (Χ2 = 7.674, p = 0.466), Nagelkerke R2
(12.1%). 64.7% of the overall cases were correctly predicted (39.7% of participants and 81.9% of nonparticipants). AUC: 0.679.
doi:10.1371/journal.pone.0146134.t002
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Table 3. Characteristics of nonparticipants.
Characteristics* All nonparticipants (n = 920) Active refusals (n = 348) Silent refusals (n = 572)
Gender of patient
Male 468 (50.9%) 188 (54.0%) 280 (49.0%)
Female 452 (49.1%) 160 (46.0%) 292 (51.0%)
Patient age
Median age (IQR) 75.5 (66.0–82.0) 77.0 (70.0–84.0) 75.0 (64.0.0–81.8)
20–49 49 (5.3%) 13 (3.7%) 36 (6.3%)
50–59 92 (10.0%) 26 (7.5%) 66 (11.5%)
60–69 146 (15.9%) 42 (12.1%) 104 (18.2%)
70–79 304 (33.0%) 121 (34.8%) 183 (32.0%)
80–89 285 (31.0%) 124 (35.6%) 161 (28.1%)
90+ 44 (4.8%) 22 (6.3%) 22 (3.8%)
Patient’s country of birth
Born in the UK or Ireland 726 (79.4%) 298 (85.9%) 428 (75.5%)
Born overseas† 188 (20.6%) 49 (14.1%) 139 (24.5%)
IMD score for lower super output area where patient lived
Median IMD score (IQR) 19.1 (10.1–32.2) 16.3 (9.2–30.4) 21.6 (10.9–33.7)
5th Quintile (least deprived) 168 (18.3%) 78 (22.4%) 90 (15.7%)
4th Quintile 155 (16.8%) 62 (17.8%) 93 (16.3%)
3rd Quintile 166 (18.0%) 68 (19.5%) 98 (17.1%)
2nd Quintile 227 (24.7%) 75 (21.6%) 152 (26.6%)
1st Quintile (most deprived) 204 (22.2%) 65 (18.7%) 139 (24.3%)
Health region where patient lived
Health region 1 260 (28.3%) 114 (32.8%) 146 (25.5%)
Health region 2 198 (21.5%) 64 (18.4%) 134 (23.4%)
Health region 3 297 (32.3%) 116 (33.3%) 181 (31.6%)
Health region 4 165 (17.9%) 54 (15.5%) 111 (19.4%)
Type of cancer (underlying cause of death)
Digestive organs 256 (27.8%) 98 (28.2%) 158 (27.6%)
Respiratory and intra-thoracic organs 199 (21.6%) 74 (21.3%) 125 (21.9%)
Eye, brain and other parts of CNS 19 (2.1%) 7 (2.0%) 12 (2.1%)
Breast 78 (8.5%) 28 (8.0%) 50 (8.7%)
Lymphoid/haematopoietic/related tissue 73 (7.9%) 22 (6.3%) 51 (8.9%)
Male genital organs 75 (8.2%) 30 (8.6%) 45 (7.9%)
Female genital organs 39 (4.2%) 11 (3.2%) 28 (4.9%)
Urinary tract 45 (4.9%) 19 (5.5%) 26 (4.5%)
Lip, oral cavity and pharynx 17 (1.8%) 3 (0.9%) 14 (2.4%)
Melanoma and skin 14 (1.5%) 6 (1.7%) 8 (1.4%)
Uncertain/unspeciﬁed/other 105 (11.5%) 50 (14.4%) 55 (9.6%)
Place of death
Home 193 (21.0%) 63 (18.1%) 130 (22.7%)
Hospital 336 (36.5%) 135 (38.8%) 201 (35.1%)
Hospice 313 (34.0%) 118 (33.9%) 195 (34.1%)
Nursing home 78 (8.5%) 32 (9.2%) 46 (8.0%)
Gender of proxy
Male 429 (52.8%) 129 (43.0%) 300 (58.6%)
Female 383 (47.2%) 171 (57.0%) 212 (41.4%)
Proxy’s relationship to patient
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patients who died from conditions other than cancer were not included in the study. People
dying from non-malignant conditions have a less predictable illness trajectory and are less
likely to access palliative care services, for example [61–63]. It is therefore possible that people’s
experiences of care and participation in research differ from those affected by cancer. Any
transferability of our results to conditions other than cancer needs to be carefully considered.
Subsequent to the present study, Evans et al. have adapted the QUALYCARE methodology to
survey the end of life care provided to people dying from non-malignant conditions [64]; their
analysis of non-response will help shed light on the factors associated with participation, active
refusals and reasons for not taking part in a similar mortality followback survey within this
patient group.
1 Factors associated with participation and providing active refusal
Since London is an urban area with an ethnically diverse population caution is needed when
generalising results to other areas. Another limitation is that QUALYCARE is a cross-sectional
survey, and any found associations do not imply causality. Finally, our regression models were
not able to explain much of the variance neither in participation nor in the provision of active
refusals. Other factors that we did not include in our models (such as complicated grief or
depression) could possibly have played a role.
1.1 Patient age. We found that proxies of older patients were more likely to take part in
the study and to give an active refusal. This supports previous findings that older age (from
patients) is associated with increased odds of participation [21,24,27–29]. Reasons for this are
not fully understood. Perhaps death is less of a shock when patients are older and as a conse-
quence people feel more able to take part (or to contact the research team to let them know
they would not like to participate if that is the case). Our results suggest that QUALYCARE
data might be more relevant to the care provided to older people. This could limit the sample
representativeness, but can provide crucial evidence for end-of-life care, as populations in need
get older [65].
1.2 Relationship to the deceased and proxy gender. Relatives other than the spouse/part-
ner were less likely to take part in our study, in contrast with a similar survey in Italy (ISDOC
Table 3. (Continued)
Characteristics* All nonparticipants (n = 920) Active refusals (n = 348) Silent refusals (n = 572)
Spouse or partner 202 (24.7%) 110 (36.3%) 92 (17.8%)
Son/daughter 429 (52.4%) 116 (38.3%) 313 (60.7%)
Brother/sister 71 (8.7%) 31 (10.2%) 40 (7.8%)
Mother/father 9 (1.1%) 3 (1.0%) 6 (1.2%)
Niece/nephew 47 (5.7%) 24 (7.9%) 23 (4.5%)
Grandson/granddaughter 14 (1.7%) 4 (1.3%) 10 (1.9%)
Other 47 (5.7%) 15 (5.0%) 32 (6.2%)
Days death registration to contact
Median days (IQR) 215.00 (166.00–258.00) 215.50 (165.25–258.00) 213.00 (167.00–259.50)
Days death to contact
Median days (IQR) 215.00 (167.00–261.00) 216.00 (166.25–260.00) 213.00 (167.00–262.00)
Abbreviations: IQR, Interquartile range; IMD, Index of Multiple Deprivation; CNS, Central Nervous System
*There were no missing data on patient’s gender, age, place of death, cancer type, region and IMD score. Missing data was 0.7% (country of birth),
11.0% (proxy’s relationship to patient), 11.7% (proxy’s gender) and 0.1% (days death to contact)
† There were 60 overseas countries of birth, none with more than 16 counts.
doi:10.1371/journal.pone.0146134.t003
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Table 4. Factors associated with giving an active refusal.
Factors Active
refusal rate
Univariate analysis p-values Multivariate analysis* p-values
n OR (95% CI) n AOR (95% CI)
Gender of patient
Male 40.0% 468 Ref. p = 0.135 407 Ref. p = 0.940
Female 35.2% 452 0.82 (0.62–1.07) 405 1.15 (0.70–1.47)
Age of patient
20–49 26.5% 49 Ref. p = 0.003 41 Ref. p<0.001
50–59 28.3% 92 1.09 (0.50–2.38) 81 1.30 (0.48–3.47)
60–69 28.8% 146 1.12 (0.54–2.32) 132 1.97 (0.77–5.02)
70–79 39.5% 304 1.81 (0.92–3.55) 262 3.42 (1.39–8.42)
80–89 43.2% 285 2.10 (1.07–4.13) 258 4.43 (1.76–
11.13)
90+ 50.0% 44 2.77 (1.16–6.59) 38 6.59 (2.12–
20.56)
Patient’s country of birth
Born in the UK or Ireland 41.0% 726 Ref. p = 0.001 646 Ref. p = 0.002
Born overseas 26.1% 188 0.51 (0.35–0.72) 166 0.49 (0.32–0.77)
IMD 2010 score
5th Quintile (least
deprived)
45.8% 168 Ref. P = 0.024 156 Ref. p = 0.530
4th Quintile 40.0% 155 0.79 (0.51–1.23) 144 0.77 (0.46–1.30)
3rd Quintile 41.1% 166 0.82 (0.53–1.27) 140 0.79 (0.46–1.36)
2nd Quintile 32.6% 227 0.57 (0.38–0.86) 201 0.66 (0.39–1.12)
1st Quintile (most
deprived)
31.9% 204 0.55 (0.36–0.84) 171 0.60 (0.32–1.12)
Health region where patient
lived
Health region 1 43.5% 260 Ref. p = 0.005 247 Ref. p = 0.988
Health region 2 32.3% 198 0.62 (0.42–0.91) 169 0.92 (0.52–1.63)
Health region 3 39.1% 297 0.83 (0.59–1.17) 268 0.97 (0.65–1.44)
Health region 4 32.1% 165 0.62 (0.41–0.93) 128 1.00 (0.58–1.74)
Type of cancer (underlying
cause of death)
Digestive organs 37.9% 256 Ref. p = 0.414 222 Ref. p = 0.513
Respiratory and intra-
thoracic organs
37.2% 199 0.97 (0.66–1.42) 176 1.03 (0.65–1.62)
Eye, brain and other
parts of CNS
36.8% 19 0.96 (0.36–2.51) 18 1.50 (0.50–4.52)
Breast 35.9% 78 0.92 (0.54–1.56) 74 1.16 (0.62–2.17)
Lymphoid/
haematopoietic/related
tissue
30.1% 73 0.71 (0.40–1.24) 64 0.58 (0.29–1.15)
Male genital organs 40.0% 75 1.09 (0.65–1.85) 67 0.97 (0.50–1.86)
Female genital organs 28.2% 39 0.64 (0.31–1.35) 34 1.07 (0.46–2.48)
Urinary tract 42.2% 45 1.20 (0.63–2.28) 39 1.35 (0.63–2.90)
Lip, oral cavity and
pharynx
17.6% 17 0.35 (0.10–1.25) 15 0.50 (0.10–2.51)
Melanoma and skin 42.9% 14 1.23 (0.41–3.65) 13 1.13 (0.31–4.17)
Uncertain/unspeciﬁed/
other
46.7% 105 1.43 (0.91–2.27) 90 1.63 (0.94–2.84)
Place of death
Home 32.6% 193 Ref. p = 0.369 183 Ref. p = 0.162
Hospital 39.9% 336 1.37 (0.94–1.99) 297 1.54 (1.00–2.38)
Hospice 37.4% 313 1.23 (0.84–1.80) 271 1.28 (0.82–1.99)
Nursing home 41.0% 78 1.44 (0.84–2.47) 61 0.93 (0.47–1.84)
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study) which found that sons and daughters were more likely to take part [22]. Family struc-
tures in Italy might help to explain these differences (e.g. strong family support and extended
families living together) [66]. In the UK, carers looking after someone in the same household
are more likely to be spouses or partners [67]. However, sons and daughters were the largest
group among the informants of death in our study, and less likely to respond than spouses and
partners. This result may be because sons and daughters may have a number of family respon-
sibilities that precludes them from taking part in research as much as spouses and partners.
They might also live in a different household (or be less involved in the care provided to the
patient) compared to the patient’s spouse or partner. It is possible that the response rate would
have improved if more spouses or partners were involved. However, cancer is a condition
strongly associated with older age [68], so it is reasonable to expect that a large number of
informants will be sons and daughters.
We also found that female proxies were more likely to participate, opposite to findings from
other studies [22,27,29]. When women did not take part, they were more likely to provide
active refusals. The association was present even after accounting for the relationship to the
deceased. Research evidence on grief suggests that men and women grieve differently, and that
men are less likely to talk about their feelings and experiences [69]; this might help explain our
results.
Table 4. (Continued)
Factors Active
refusal rate
Univariate analysis p-values Multivariate analysis* p-values
n OR (95% CI) n AOR (95% CI)
Gender of proxy
Male 30.1% 429 Ref. p<0.001 429 Ref. p = 0.007
Female 44.1% 383 1.84 (1.38–2.45) 383 1.58 (1.14–2.20)
Proxy’s relationship to
patient
Spouse or partner 54.0% 202 Ref. p<0.001 202 Ref. p<0.001
Son or daughter 26.8% 429 0.31 (0.22–0.44) 429 0.26 (0.18–0.40)
Brother or sister 43.7% 71 0.66 (0.38–1.14) 71 0.88 (0.48–1.61)
Parent 33.3% 9 0.43 (0.10–1.75) 9 0.89 (0.17–4.84)
Niece/nephew 51.1% 47 0.89 (0.47–1.68) 47 0.59 (0.28–1.22)
Grandchild 28.6% 14 0.34 (0.10–1.12) 14 0.19 (0.05–0.70)
Other 31.9% 47 0.40 (0.20–0.78) 40 0.25 (0.11–0.56)
Days from death to contact
110–150 37.1% 143 Ref. p = 0.950 128 Ref. p = 0.474
151–180 37.4% 163 1.02 (0.64–1.62) 145 1.08 (0.62–1.87)
181–210 34.6% 136 0.90 (0.55–1.46) 124 0.79 (0.44–1.42)
211–240 38.6% 153 1.07 (0.67–1.71) 132 1.10 (0.63–1.93)
241–270 41.7% 132 1.21 (0.75–1.97) 125 1.43 (0.81–2.53)
271–300 37.5% 144 1.02 (0.63–1.64) 115 0.90 (0.50–1.63)
301–330 35.4% 48 0.93 (0.47–1.84) 43 0.75 (0.33–1.69)
Abbreviations: UK, United Kingdom; IMD, Index of Multiple Deprivation; CNS, Central Nervous System;
OR, odds ratio; AOR, adjusted odds ratio; CI, conﬁdence intervals
*All characteristics of the patients and the informants of death, including timing of contact were entered
simultaneously in the regression model (N = 812, excluding 108 cases with missing data, i.e. 11.7% of all
920 cases). Model-ﬁtting statistics: Hosmer and Lemeshow (Χ2 = 7.883, p = 0.445), Nagelkerke R2
(20.3%). 70.1% of the overall cases were correctly predicted (41.0% of active refusals and 87.1% of silent
refusals). AUC: 0.732.
doi:10.1371/journal.pone.0146134.t004
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Table 5. Classification of reasons for refusal.
Categories Sub-categories n* kappa n disagreements
Study-related Total study-related 126
Questions not applicable (e.g. died quickly, complex case, treated privately) 22 0.901 3
Questions upsetting/stressful/intrusive/insensitive 18 0.852 5
Approach or correspondence upsetting/”crossed”/ no further contact/off the list 18 0.906 3
Prepared or tried to ﬁll in but was not able to 16 0.797 6
Questions bring it all back, bring memories 15 0.836 4
Length of questionnaire/ too many details/too many boxes 13 0.847 4
Feels study will not make any difference or has hidden agenda 12 0.954 1
Questionnaire too complicated to complete (e.g. for elderly) 5 0.795 2
Questions irrelevant, do not cover what person wishes to say 5 0.659 3
Disapproves not being warned before receiving questionnaire 2 0.798 1
Proxy-related Total proxy-related 88
Relative or friend with limited knowledge/involvement in care (e.g. not present) 21 0.894 4
Professional, care home manager, lawyer, funeral ofﬁcer (no family around) 19 0.942 2
Limited knowledge/involvement but unclear if relative/friend or professional 14 0.856 4
Potential respondent unwell, ill, disabled 9 0.870 2
Cannot remember/recall requested information 9 0.870 2
Does not wish to distress best person to answer 6 0.795 2
Does not take part in surveys/does not want to ﬁll in forms 5 0.828 2
Death of potential participant 3 1.000 0
Participation in another study 2 0.664 1
Grief-related Total grief-related 88
Still grieving/still shocked/still raw/would be upsetting, distressing or painful 39 0.935 4
Bad/traumatic/painful experience and times (not explicitly about care) 19 0.915 3
Does not want to be reminded (e.g. go over, go back) 10 0.950 1
Too soon, too early 9 0.895 2
Too late, far down the line to go back over 6 0.907 1
Too many things to sort out (e.g. deceased’s paperwork) 5 1.000 0
Life-related Total life-related 16
Busy life, no time (e.g. kids, home to run) 5 0.907 1
Busy caring for someone ill at moment 3 0.496 2
“move on” events (e.g. moved house, had grandchild) 4 0.745 2
“problematic” events (e.g. other relative died) 4 1.000 0
Care-related Total care-related 8
Bad/traumatic care experiences 6 0.657 4
Feels nothing more to be said about care received 2 -0.005 2
Non-speciﬁc Total non-speciﬁc 14
Does not wish to/feel like doing it but no reason given 7 1.000 0
Difﬁcult/cannot manage/does not feel able but no reason given 7 0.870 2
Other Any other reason not described above † 10 0.502 17
* 205 non-participants volunteered reasons for refusal; N cells do not add to 205 as non-participants provided one reason (n = 127), two (n = 38), three
(n = 22), four (n = 10), ﬁve (n = 6), six (n = 1) or seven (n = 1).
† Included use of incorrect title in invitation letter (e.g. Ms instead of Mrs) (n = 2), NHS complaint procedure regarding care in process (n = 1),
conﬁdentiality and data safety concerns (n = 1), potential participant was Spanish and did not know how to complete the questionnaire (n = 1), passed
questionnaire to patient’s partner (n = 1), was a social worker and “would say that palliative care was excellent”(n = 1), stated there was not enough
contact with hospital (not clear if own or patient contact) (n = 1), patient residence outside studied areas (n = 1), asked other relative to help but person
could not help either (n = 1).
doi:10.1371/journal.pone.0146134.t005
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Table 6. Examples of reasons for refusal by main category*.
STUDY-RELATED
REASONS
“The questions asked are intrusive and upsetting. Asking questions like ‘how
did you feel in the last week of his life’? How do you think we felt?”
“I felt the questionnaire was too long and some questions were too similar.
Also frustrating was a lot of questions weren't relevant to my family member's
death. The three month time span placed also made the survey awkward as
she was only aware of her condition for a few weeks”
“If I thought the questionnaire would make any difference, I would ﬁll it out”
“It is very difﬁcult to ﬁll in this form as my mother-in-law had for the last 3
years of her life been blind, practically paralysed in both arms and legs and
unable to communicate, therefore I ﬁnd that most questions contradict
themselves in one way or another”
“My mother was in a coma for the last 6 months of her life which was spent in
a nursing home. As most of the questions did not apply to her I did not think
it would be much help to you”
“The questionnaire does not cover the things that I would wish to say related
to the death of my late wife [name]. I have only admiration for the treatment
she received at hospital [name]. Her treatment at hospital [name] was the
complete reverse. I would however be happy to converse with someone from
your organisation on a one to one basis be it via a telephone conversation or
a face to face interview”
PROXY-RELATED
REASONS
“I am not the best person to complete this questionnaire, as I only visited my
uncle once in hospital before his death. The people who helped and visited
him a lot are friends (locally). I do not have their addresses”
“We are only the solicitors dealing with the Estate of the deceased. We did
not have any involvement with his care”
“I am sorry to say this survey is beyond my mother who is now 84 and
struggling with breast cancer following my father's death. These surveys are
far too complicated for some elderly people”
“I passed the original questionnaire to my sister as she was [name]'s partner
and it seemed most appropriate for her to take part. I don't really want to
keep asking her about whether she wants to take part as I imagine it would
be a difﬁcult thing for her to do so not sure if you'll get a response”
GRIEF-RELATED
REASONS
“It has not been a year yet since I lost my loved one and am too upset at
present to talk about them”
“I just feel it is too early as I am still grieving”
“I am having great difﬁculty coping with the loss of my husband please do not
send any more mail to me”
“It is still painful to sit and ﬁll in questions of such a private time, I am not
emotionally ready”
LIFE-RELATED
REASONS
“I work full-time and have children and a home to run and as much as I would
like to help I just don't have the time. Apologies”
“I am very sorry I am not able to answer your questionnaire. I have been and
still am caring for my husband 24/7. He is aged 91 years and he needs me”
CARE-RELATED
REASONS
“Having lost my dear brother at the age of 55 years in hospital, who died like
a dog and was treated like one for most of his life (. . .) Therefore I do not feel
I can take part”
“She was wonderfully looked after, [I have] nothing to comment more on the
care provided to her”
NOT SPECIFIC “I don't wish to, thank you, I don't want to be involved in this”
OTHER REASONS “I do not trust any government department whatsoever to keep information
conﬁdential, safe or secure. Therefore I will not take part in your survey”
*To show quotes by main categories we did not give examples of multidimensional reasons given by one
single nonparticipant when these overlapped different main categories.
doi:10.1371/journal.pone.0146134.t006
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1.3 Place of death. Proxies of patients who died in hospital were less likely to return a
completed questionnaire compared to proxies of patients who died at home. Our results
are similar to those from the ISDOC study in Italy [22]; other studies in the UK also found
higher response for proxies of patients who died at home [24,43,57]. None of these studies,
however, discussed explanations and it is possible that the reasons are multifactorial. Impor-
tantly, in the main analysis of the QUALYCARE study we found that a home death was
more peaceful for patients than death in hospital and resulted in less intense grief for proxies,
after adjusting for confounders [70]. This is consistent with evidence stating that people
experiencing fewer problems and having more positive views about the care received may
be more likely to return a completed questionnaire [71]. It is also possible that proxies of
patients who died at home knew more about the care provided and felt more able to contrib-
ute to the study.
1.4 Social deprivation and country of birth. Social deprivation was associated with par-
ticipation in univariate analysis, but lost statistical significance after adjusting for confound-
ing factors. This might have occurred because people living in deprived areas are more
likely to die at a younger age and in hospitals [72]. Both patient’s age and hospital death were
associated with participation in our study. In our multivariate analysis investigating factors
associated with active refusal, deprivation also lost statistical significance and this may be
because patients born overseas (whose proxies were less likely to give active refusals) usually
live in more deprived areas, especially in inner London [58]. Our findings suggest that other
factors might play a bigger role than deprivation itself, but any conclusions need to be seen
with caution and the topic warrants more research. Furthermore, deprivation is an area level
variable rather than an individual level variable and there is the risk of ecological fallacy.
Those living in a more deprived area are not necessarily deprived. Likewise, those who live in
a less deprived area can actually be deprived. This is especially true in London, where health
regions can have an unusual spatial distribution of both very affluent and very poor residents
[73].
Proxies of patients who were born overseas (as opposed to being born in the UK/Ireland)
were more likely to provide an active refusal. Almost half of the proxies of patients who were
born overseas (139/287) were nonparticipants who did not actively refuse to take part. That
means not only we have less knowledge about the care this patient group received, but we also
do not know why their proxies did not participate. This could be due to several reasons (i.e.
language barriers, different ways of grieving). Adding a note to the back of the questionnaire in
different languages so potential participants know that they can have a translated version if
required may be a helpful approach. Reaching out for these groups is a necessity in future
research to help provide the best possible care for all, regardless of their country of origin or
background.
1.5 Timing of contact. Interestingly, timing of contact was not a significant factor in our
study, contrary to findings from the ISDOC study in Italy [22]. This was the only study with
bereaved relatives we could identify which also investigated the association of timing of contact
with participation using multivariate analysis. Authors found that an increased interval from
death to receiving the questionnaire made participation less likely. In QUALYCARE, although
the majority of participants returned questionnaires 4–10 months after the patient’s death, 97
questionnaires were returned 11 to 12 months after the patient had died (six questionnaires
were returned even later than that). Furthermore, eight potential participants who had refused
to take part changed their minds and later returned a completed questionnaire. Perhaps this
is a benefit of postal surveys; they give people more time to consider taking part than they
would have on a face-to-face contact, and also more time to think about what the questionnaire
requires and whether to respond to it.
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2 Reasons for refusal
Our content analysis of reasons for refusal was limited by the comments we received. Since
most of them were brief we were not able to carry out an in-depth analysis. Furthermore,
although our study shed light on reasons why people did not take part, reasons for nonpartic-
ipation were unknown for the majority of nonparticipants (77.7% or 715 non-participants).
This group includes 143 proxies who actively refused to take part without giving any reasons
and 572 silent refusals. Their reasons might differ from the ones we received. It is also
worth noting that the reasons for refusal provided over the telephone were not transcribed
verbatim as conversations were not recorded. It is possible that researcher bias happened as a
consequence.
Our findings show that more than a third (37.8%) of nonparticipants provided an active
refusal, and more than half (58.9%) of those justified their reasons. Including reply slips in
questionnaire packs seems to be an effective strategy to understand better the reasons for not
taking part in cancer mortality followback surveys.
As expected based on the literature, grief is an important reason for refusal [22,36–39];
although in our study it was not the most common reason (accounting for a quarter of all rea-
sons provided). This suggests that no matter how sensitively developed a questionnaire is,
some potential participants will just not feel ready to respond. It is also possible that grief was
underestimated as a refusal reason as people experiencing intense grief might be among those
who did not contact the research team in any way.
Refusal reasons related to a perceived lack of knowledge about the care provided points to a
limitation of using death registration data, since not all who register someone’s death have
information about the care received by the patient. On the other hand, this suggests that the
completed questionnaires can provide a more accurate picture of people’s experiences (since
participants would have felt that they had sufficient knowledge to complete them). However,
this also indicates that the study might be underrepresenting patients without informal carers
or family around.
Proxy-related reasons also raise the issue about contacting informal carers who are some-
times fragile and disabled. In the context of an ageing population [65], this is likely to become a
more common pattern in the future. The need to develop simpler, shorter questionnaires that
are not burdensome to informal carers is then even more urgent. Questionnaire length was
also highlighted as a study-related reason for refusal. Nonetheless, it is possible that a short
questionnaire could be perceived by some as not doing enough justice to a life event as mean-
ingful and salient as the end of life care received by a close one. Emphasising the importance of
the study (and how it might benefit other patients and families in the future), working carefully
on sensitive questions and leaving scope in the questionnaire for different care situations
should also be a way forward. This can be challenging depending on the study aims (and when
trying to develop shorter surveys).
3 Implications for research
Although the QUALYCARE study shed light on factors associated with participation while
accounting for a number of potential confounders, further multivariate analyses of similar
studies are still needed.
The need for more research is especially critical regarding the views and experiences of
patients dying in hospitals and those without informal carers. Better representativeness might
be achieved by using different proxies (such as care staff instead of close friends or relatives),
by having questionnaires translated to different languages, being culturally sensitive when
developing tools, among others. Targeted prospective studies instead of mortality followback
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surveys might also be more appropriate to reach out for these groups. Results from mortality
followback surveys focused on non-cancer will be crucial to build evidence on non-response
for proxies of patients with non-malignant conditions. Finally, investigating effective ways to
reduce the questionnaire length in future studies may help to improve response rates.
Conclusion
In summary, our results show that proxies of older patients, female informants and patient’s
spouses were more likely to take part in a postal mortality followback survey designed to assess
quality of end of life care provided to patients dying from cancer, whilst patients dying in hos-
pitals were underrepresented. We also had little information about reasons for non-participa-
tion from proxies of patients who were born overseas. Changes to the study design and
methods might help to increase RRs (as study-related reasons were the most commonly men-
tioned reasons for refusal), but it is important to be aware that reasons for refusal are often
multidimensional and that grief is a common reason that must be accounted for and respected.
We used a robust, validated methodology to survey bereaved relatives and had a powered
sample of a population dying from cancer in a metropolitan area in the UK. Our findings add
much needed evidence to the field of end-of-life care studies with bereaved relatives. However,
we still need further powered studies that use robust research methods. We also need to investi-
gate different approaches which might be more appropriate to reach underrepresented groups.
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